Physician profile
Pegah Ghamasaee
NPI 1376071407
$6,745.66
in general payments reported to CMS, 2019-2025
10 companies · $1,735 in 2025
The $1,735 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $5,011 · 2025: $1,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,657 · Food and Beverage: $3,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,656.89 |
| Food and Beverage | $3,088.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,428.79 | 2024 | Viper, Conduit |
| Aesculap, INC. | $1,029.16 | 2024 | No Applicable Marketed Product Name |
| Medtronic, INC. | $890.99 | 2024-2025 | Mazor X System, Stealthstation S8 Platform, Cd Horizon Spinal System |
| Synthes Gmbh | $830.88 | 2024 | |
| Depuy Synthes Sales INC. | $482.80 | 2024-2025 | Acis, Symphony, Obelisc Vertebral Body Replacement |
| Stryker Corporation | $377.79 | 2024-2025 | Core, Universal Neuro 3, Na |
| Cerapedics INC. | $344.39 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $170.46 | 2025 | Fortify, Altera, Hedron |
| Si-Bone, INC. | $152.07 | 2024 | |
| Spinal Elements, INC. | $38.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pegah Ghamasaee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.